JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sijzuoki-Ziro,
Right arrow Articles by Numata, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sijzuoki-Ziro,
Right arrow Articles by Numata, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 2, 353-364, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


URINARY METABOLITES OF THIAMINE TETRAHYDROFURFURYL DISULFIDE IN RATS

Sijzuoki-Ziro 1, Kishiko Murakami 1, Shintaro Kikuchi 1, Kohei Nishikawa 1, and Mitsuo Numata 1

1 Biological Research Laboratories and Chemical Research Laboratories, Research and Development Division, Takeda Chemical Industries, Ltd., Osaka, Japan

Most of the radioactivity was eliminated exclusively into the urine when thiamine tetrahydrofurfuryl disulfide-S35 (outer) was fed to rats. The metabolites were isolated by chromatographic fractionation using silicic acid or a hyldietaminoethyl Sephadex anion exchanger. The isolated metabolites were compared with synthetic standards and were characterized chemically by isotope dilution, infrared analysis, nuclear magnetic resonance and mass spectrometry. About 90% of the urinary radioactivity was thus identified as ugr-hydroxy-dgr-methylsulfonyl valerie acid (50-70%), methyl tetrahydrofurfuryl sulfoxide (15-30%), ugr-hydroxy-dgr-methylsulfinyl valerie acid (4-7%), methyl tetrahydrofurfuryl sulfone (2-4%) and inorganic sulfate (3-6%). The hydroxy valerie acid metabolites were converted to the corresponding ugr-lactones by treatment with acid, and the identity of the lactones was also established by spectroscopy, mass spectrometry and isotope dilution. Time course studies on metabolite pattern show that ugr-hydroxy-dgr-methylsulfonyl valeric acid is a main and terminal product. The present studies add further evidence for the importance of the methylsulfonyl pathway in the biotransformation of foreign alkyl mercaptans.

Submitted on January 3, 1967
Accepted on July 7, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.